No abstract

This article has been peer reviewed and published immediately upon acceptance.It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited.

No abstract

Introduction: Diffuse Large B Cell Lymphoma (DLBCL), the most common non-Hodgkin lymphoma, despite having a standard of care treatment (R-CHOP), has heterogeneous clinical and molecular features. The widely used risk scores are based on clinical and

No abstract

No abstract